International Vaccine Access Center
Rotavirus Accelerated Vaccine Introduction Network (RAVIN), Benin
Benin is among dozens of Gavi-eligible countries to introduce rotavirus vaccines in the past several years to prevent a severe form of diarrheal disease responsible for over 180,000 deaths globally each year. Children should receive three doses of rotavirus vaccine between 6 and 14 weeks of age, and these three doses will protect him or her against this form of severe acute diarrhea. The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) project supported Benin in preparing for the introduction of rotavirus vaccine, which began in December 2019. The rotavirus vaccine introduction planning process was an opportunity to strengthen the country’s routine immunization program, build capacity, and mitigate delays. RAVIN is a partnership between the Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), John Snow Research and Training Institute (JSI), and the U.S. CDC providing strategic technical assistance in Afghanistan, Bangladesh, Cambodia, the Democratic Republic of the Congo, Lao PDR, Myanmar, and Nepal. Its support, which complements services and leadership provided by WHO, UNICEF, and Expanded Program on Immunization (EPI) teams, encompasses rotavirus vaccine introduction decision-making, Gavi applications, introduction preparation, implementation, and impact assessments.
Rotavirus Accelerated Vaccine Introduction Network (RAVIN), Benin
Benin is among dozens of Gavi-eligible countries to introduce rotavirus vaccines in the past several years to prevent a severe form of diarrheal disease responsible for over 180,000 deaths globally each year. Children should receive three doses of rotavirus vaccine between 6 and 14 weeks of age, and these three doses will protect him or her against this form of severe acute diarrhea. The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) project supported Benin in preparing for the introduction of rotavirus vaccine, which began in December 2019. The rotavirus vaccine introduction planning process was an opportunity to strengthen the country’s routine immunization program, build capacity, and mitigate delays. RAVIN is a partnership between the Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), John Snow Research and Training Institute (JSI), and the U.S. CDC providing strategic technical assistance in Afghanistan, Bangladesh, Cambodia, the Democratic Republic of the Congo, Lao PDR, Myanmar, and Nepal. Its support, which complements services and leadership provided by WHO, UNICEF, and Expanded Program on Immunization (EPI) teams, encompasses rotavirus vaccine introduction decision-making, Gavi applications, introduction preparation, implementation, and impact assessments.